-
July 26: The Week in Cancer News
Double mastectomy doesn’t lead to a survival advantage over lumpectomy or single mastectomy, and research explores hearing loss linked to cisplatin.
by Marci A. Landsmann
-
July 19: The Week in Cancer News
Education about mammography is linked to reduced screening for women in their 40s, and pancreatic cancer discovery could lead to new treatments.
by Kevin McLaughlin
-
July 12: The Week in Cancer News
Standard screening may not catch endometrial cancer in Black women, and a cancer patient receives a voice box transplant for the first time.
by Thomas Celona
-
July 5: The Week in Cancer News
Neuropathy may be prevented with an exercise program, and prostate cancer screening standards may not be appropriate for transgender women taking estrogen.
by Eric Fitzsimmons
-
June 28: The Week in Cancer News
Acupuncture helps manage side effects of endocrine therapy, and adding chemotherapy before surgery delays progression in pancreatic cancer.
by Marci A. Landsmann
-
June 21: The Week in Cancer News
Risk for cancer and cardiovascular disease linked to air pollution, and three cancer drugs could face generic competition by 2028.
by Kevin McLaughlin
-
June 14: The Week in Cancer News
Lung cancer screening linked to lower mortality in real-world data, and researchers study unusual cancer patterns after COVID-19 infection.
by Eric Fitzsimmons
-
June 7: The Week in Cancer News
Research supports reducing the intensity of cancer treatment, and barriers can prevent members of the LGBTQ+ community from receiving cancer screening and care.
by Thomas Celona
-
May 31: The Week in Cancer News
Young adults often ignore telltale signs of colorectal cancer, and more evidence supports active surveillance for low-risk prostate cancer.
by Marci A. Landsmann
-
May 24: The Week in Cancer News
New immunotherapy approved for small cell lung cancer, and researchers investigate using urine tests to detect cancer.
by Kevin McLaughlin
Cancer Talk
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live Longer
Findings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
Cancer Today Editors’ Picks: 2024Our favorite Cancer Today stories from 2024, as picked by the editors.